News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Sean Kent

Articles by Sean Kent

104 KATSIS-1: Randomized Phase 3 Trial Evaluating KAT6 Inhibitor PF-07248144 (prifetrastat) Plus Fulvestrant in HR+HER2− Advanced/Metastatic Breast Cancer After Progression on CDK4/6 Inhibitor-Based Therapy

ByKevin Kalinsky, MD, MS,Rachel M. Layman,Antonio Giordano,Toru Mukohara,Yeon Hee Park,Geoffrey J. Lindeman,Giampaolo Bianchini,Alexandre de Nonneville,Véronique Diéras, MD,Sherko Kuemmel,Shusen Wang,Zhiming Shao,Sean Kent,Griffith M. Davis,Meng Li,Mafalda Oliveira

May 19th 2026

Latest Updated Articles

Trending on CancerNetwork

Toxicity From CD19, BCMA Therapy May Inform B-Cell Malignancy Surveillance

Sac-TMT Significantly Improves PFS/OS in Pretreated Endometrial Cancer

Nogapendekin Alfa Plus BCG Exhibits Efficacy Advantage in NMIBC In Situ

105 Real-World Overall Survival With Palbociclib Plus an Aromatase Inhibitor (AI) in Overweight/Obese Patients With HR+/HER2− Metastatic Breast Cancer (MBC)

Frontline Sevabertinib Earns FDA Priority Review in HER2-Mutated NSCLC